FIBROGEN INC - Common Stock, $0.01 par value (FGEN)

Historical Holders from Q4 2014 to Q3 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
FGEN on Nasdaq
Shares outstanding
100,740,741
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
0
Total reported value
$0
Share change
-15,000
Value change
-$79,500
Avg sell value change
-0%
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.4% +24% $2,805,000 +$561,000 8,500,000 +25% Armistice Capital, LLC 31 Mar 2025
PRIMECAP MANAGEMENT CO/CA/ 4.6% $1,523,323 4,616,130 PRIMECAP MANAGEMENT CO/CA/ 31 Dec 2024

Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 0 $0 -$79,500 0
2025 Q2 15,000 $79,500 -$10,137,427 530% 1
2025 Q1 32,974,661 $10,217,322 -$1,814,128 30.99% 52
2024 Q4 36,261,009 $19,199,469 -$4,577,110 52.95% 65
2024 Q3 45,933,468 $18,857,141 -$6,430,829 39.94% 68
2024 Q2 56,537,431 $50,439,989 -$9,081,706 89.23% 100
2024 Q1 61,231,274 $143,890,300 -$18,865,510 235% 106
2023 Q4 70,070,394 $62,097,852 +$1,475,033 88.63% 99
2023 Q3 68,326,642 $58,948,042 -$26,264,926 86.29% 106
2023 Q2 76,278,245 $205,953,752 -$161,076,321 270% 149
2023 Q1 76,360,130 $1,424,871,632 +$28,986,682 1,866% 171
2022 Q4 74,882,455 $1,199,512,447 +$34,809,045 1,602% 143
2022 Q3 73,058,455 $950,485,507 +$31,367,178 1,300.99% 146
2022 Q2 70,661,940 $746,891,350 +$29,354,270 1,056% 145
2022 Q1 67,898,538 $816,547,036 +$18,128,716 1,202.01% 150
2021 Q4 66,279,662 $934,552,606 +$30,528,224 1,410% 157
2021 Q3 64,052,510 $654,426,634 -$173,048,089 1,022% 156
2021 Q2 67,744,971 $1,804,059,935 -$97,241,940 2,663% 170
2021 Q1 71,176,129 $2,470,272,742 -$31,512,282 3,471% 190
2020 Q4 71,979,588 $2,669,848,746 +$83,550,338 3,709% 202
2020 Q3 68,946,106 $2,836,067,721 +$69,119,809 4,111.97% 205
2020 Q2 67,276,990 $2,726,519,660 +$109,940,747 4,052.99% 188
2020 Q1 64,502,523 $2,241,446,114 +$113,121,712 3,475% 183
2019 Q4 61,421,765 $2,634,618,707 +$38,703,669 4,288.98% 208
2019 Q3 60,775,042 $2,247,652,301 -$21,551,953 3,698% 207
2019 Q2 61,289,161 $2,767,887,727 +$155,500,176 4,517.95% 188
2019 Q1 57,939,233 $3,149,200,949 +$65,047,180 5,434.99% 221
2018 Q4 56,762,525 $2,626,788,611 -$105,914,649 4,627.99% 193
2018 Q3 55,858,822 $3,393,439,085 -$20,598,295 6,075.03% 184
2018 Q2 56,215,445 $3,519,052,177 +$181,537,369 6,260% 191
2018 Q1 53,304,011 $2,461,921,610 +$130,270,299 4,620% 191
2017 Q4 50,164,786 $2,377,778,005 +$98,540,023 4,740% 184
2017 Q3 47,853,028 $2,575,637,958 +$551,224,666 5,380% 178
2017 Q2 37,906,037 $1,224,325,864 +$269,590,730 3,230% 148
2017 Q1 31,065,653 $765,766,533 +$132,773,177 2,464.95% 141
2016 Q4 30,158,684 $645,408,993 -$11,768,672 2,140% 135
2016 Q3 30,813,510 $637,314,781 -$11,901,357 2,070% 130
2016 Q2 31,596,562 $518,493,981 -$37,231,328 1,641% 142
2016 Q1 32,866,063 $699,483,000 +$21,624,319 2,128.95% 133
2015 Q4 31,602,316 $963,138,246 +$96,196,195 3,046.99% 134
2015 Q3 28,567,119 $626,149,001 +$76,703,412 2,192% 114
2015 Q2 24,227,264 $569,258,893 +$191,161,902 2,350% 93
2015 Q1 15,163,150 $469,917,602 +$11,939,137 3,137.97% 74
2014 Q4 14,814,221 $399,875,130 +$388,893,130 2,733.75% 65